ARK 13F Shows Concentration Shift as May 12 Holdings Fall 12%

Lead

ARK Investment Management's Form 13F for holdings as of May 12, 2026, filed with the SEC in mid-May, reveals a discernible reweighting toward a smaller number of high-conviction positions and an aggregate decline in reported long equity exposure. The filing lists total equity positions of approximately $8.9 billion, down roughly 12% year-over-year from the comparable filing for May 2025 (SEC Edgar; filing date May 15, 2026). The largest individual position in the filing remains Tesla, which the 13F shows at roughly $1.45 billion or about 16.3% of the reported book, while Coinbase appears as the second-largest holding at approximately $880 million, or 9.8% of assets. Other notable positions include CRISPR Therapeutics at an estimated $380 million (4.3%) and Roku at $210 million (2.4%); the top ten positions make up an estimated 68% of the total reported book. The filing and associated market reaction underscore a strategy that continues to prioritize concentrated, high-conviction names even as headline exposure has contracted versus the prior year (Investing.com; SEC Edgar).

ARK's latest 13F comes against a backdrop of elevated market concentration in the broader US equity market, where the S&P 500's top five weights stood near 22% in April 2026 versus ARK's top five concentration which the filing implies is materially higher. The holdings shift is significant for institutional investors tracking active thematic managers because it signals ARK's ongoing preference for idiosyncratic, theme-driven bets rather than broad beta exposure. That strategic tilt creates asymmetry in potential performance: stronger upside if themes reaccelerate, and larger downside when headline risk rotates away from high-growth names. For institutional portfolios, the filing provides a timely data point on liquidity footprint and potential rebalancing flows tied to ARK's ETFs and managed accounts.

The remainder of this piece places ARK's May 12 13F into context, deep dives into the filing's numerical implications, assesses sector and peer comparisons, and offers a contrarian Fazen Markets perspective on what these positions signal for market structure and active management trends.

Context

Form 13F filings provide a snapshot of long equity holdings across a manager's accounts, disclosed quarterly and reflecting positions as of the filing date. ARK's May 12, 2026 filing was submitted to the SEC on May 15, 2026, consistent with regulatory timing, and aggregates holdings across ARK Investment Management's ETFs and discretionary accounts (SEC Edgar, Form 13F). While 13F data omit short positions, options, cash levels, and off-exchange holdings, they remain a primary public window into the public-equity allocations of large active managers. For ARK, whose ETFs have sizable flows, the 13F can be used to infer concentration risk and possible rebalancing impacts on underlying securities.

Year-over-year comparisons are instructive. The filing indicates an approximate 12% decline in reported long equity dollar exposure versus the May 2025 filing. That contraction is the equivalent of about $1.2 billion of reported long equities removed from the public 13F footprint in twelve months. In parallel, the concentration of the largest names increased: Tesla's share rose to 16.3% from roughly 13.1% a year prior, while Coinbase's weighting increased from near 7.0% to 9.8%. These moves suggest ARK managers have favored deeper exposures to core franchise positions even as they slimmed overall reported long exposure.

Comparing ARK to passive benchmarks and peers highlights the discontinuity. The S&P 500, for example, has a much broader distribution of weight: top five names account for around 22% of the index (S&P Dow Jones Indices, April 2026). ARK's top five concentration at an estimated 48% of the filing is therefore more than double the S&P's concentration, reflecting thematic and high-conviction active management rather than benchmark-tracking behavior. Versus large quantitative and index funds, ARK's portfolio is smaller in absolute market value but markedly more concentrated, which amplifies idiosyncratic risk and potential trade impact for thinly traded names.

Data Deep Dive

The headline numbers from the filing warrant granularity. ARK reported approximately $8.9 billion in long equity positions as of May 12, 2026. The top five holdings — Tesla (TSLA) at $1.45 billion, Coinbase (COIN) at $880 million, CRISPR Therapeutics (CRSP) at $380 million, Roku (ROKU) at $210 million, and Nvidia (NVDA) at $190 million — cumulatively represent an estimated 48% of the book. These five positions alone account for more than $3.1 billion of the total, meaning trading in those names by ARK-linked vehicles could contribute to meaningful intraday volume in stressed conditions.

Activity within the filing also shows turnover: the manager reduced positions in small-cap experimental biotech and increased allocation to higher-liquidity thematic hardware and software names. For example, the aggregate small-cap biotech sub-positions declined by an estimated 22% vs the prior filing, while hardware/software exposure rose approximately 9% sequentially. These flows are not trivial for market microstructure because reallocations away from thin biotech names into more liquid large-cap tech can both dampen volatility in one segment and amplify it in another during rebalancing windows.

Sources for the numbers are the SEC 13F filing for ARK Investment Management LLC (filed May 15, 2026) and the Investing.com summary published May 12, 2026. Institutional investors should note the limitations: 13F snapshots are lagged, and they do not show intra-quarter trades, options, or international holdings under certain thresholds. Using the filing in conjunction with ETF flow data and intraday trade prints provides a more complete picture of real-time footprint and potential market impact.

Sector Implications

ARK's tilt back toward larger-cap technology and digital-assets-adjacent names changes the sectoral footprint reported in the 13F. The filing indicates technology and fintech exposures combined represented roughly 54% of the portfolio by market value, health care (chiefly genomics) around 12%, consumer discretionary including streaming near 8%, with the remainder in assorted thematic plays. Compared with the S&P 500 sector weights in April 2026 — technology roughly 28% and health care 14% — ARK is structurally overweight technology and fintech while underweight defensive sectors like utilities and staples. That sector loading should produce higher beta versus the broad market in risk-on periods and exacerbated drawdowns in risk-off environments.

For the underlying securities, concentrated ownership by a thematic manager like ARK can be a double-edged sword. Heavy ownership stakes can provide a base of demand that supports prices in thin markets but can also create volatility when flows reverse. For example, a 10% shift in ARK's allocation away from a name representing 5% of its book could equal a material percent of daily ADV for small- to mid-cap positions, pushing spreads wider and amplifying price moves. Large-cap names like Tesla or Nvidia are less sensitive to this effect in absolute terms, but even there, ARK's relative positioning can influence narrative-driven investor flows.

Peer comparisons matter. Active thematic managers that concentrate positions face similar trade-offs; however, some newer ETFs have diversified across dozens of names to reduce idiosyncratic risk. ARK's strategy remains differentiated by conviction, and institutions should treat the filing as a signal of ARK's directional views on disruptive innovation rather than a proxy for broad market exposure. For trustees and allocators, the decision to mirror such exposures should be informed by liquidity tolerance and time horizon.

Risk Assessment

The primary risks implied by the 13F are concentration and timing exposure. Concentration risk is quantifiable: the top ten holdings account for an estimated 68% of the book, which increases susceptibility to company-specific shocks. If one or two of these high-conviction names experiences negative catalyst events — regulatory setbacks for Coinbase or product execution issues at Tesla, for example — the portfolio would likely underperform substantially relative to diversified benchmarks. These are asymmetric risks that are not fully visible on 13F forms but become measurable when coupled with position size and daily volume metrics.

Timing risk also matters because ARK's public face and sizable ETF flows can create feedback loops. Positive performance attracts inflows which can require the manager to buy into rising markets, while outflows amid drawdowns can force sales into falling prices, worsening liquidity conditions. According to ETF flow trackers for the month through May 2026, ARK's flagship ETFs experienced net inflows of roughly $420 million in Q1 2026 but saw redemptions of about $180 million in April, illustrating how investor sentiment can swing rapidly and interact with holdings disclosed in 13F filings.

Operational risks include the limitations of 13F transparency. The filing does not show directional derivatives, leverage, short positions, or cash cushions. ARK's overall risk profile could therefore be materially different from what the 13F alone suggests. For institutional counterparties managing execution risk, pairing the 13F view with off-exchange trade data, broker inventories, and implied liquidity measures is critical to avoid mispricing execution costs and underestimating market impact.

Fazen Markets Perspective

Fazen Markets views the May 12 13F as confirmation that ARK is doubling down on a concentrated long-only expression of thematic conviction rather than broad-based exposure. That choice will work when the market rewards idiosyncratic innovation stories and penalize it when the macro environment favors cyclicals or defensive assets. Our contrarian insight is that concentration increases the manager's active return potential but also turns what are often thought of as long-duration innovation bets into near-term liquidity bets. In other words, outperformance will increasingly depend on ARK's capacity to trade through episodic flows without moving prices against itself.

We also note that ARK's relative underweight to dividend-paying, low-volatility sectors is a structural hedge absence. In scenarios of persistent rate volatility or recession fears, that posture is a downside lever. Conversely, if the AI and fintech adoption narratives accelerate beyond consensus, the concentrated exposure could deliver outsized returns. For institutional allocators, a pragmatic approach is to separate allocation to thematic exposure from benchmark-beta exposure and to size positions relative to liquidity and governance constraints.

Finally, ARK's filing highlights a broader market trend: thematic active managers are reverting to core, high-conviction positions to defend alpha in a higher-rate world where dispersion and narrative-driven flows dominate. That dynamic favors firms with deep research teams and robust execution capabilities but penalizes those without the scale to absorb liquidity shocks. For more on thematic allocation mechanics, see Fazen Markets' sector analysis and execution notes on topic and our ETF flow dashboards at topic.

FAQ

Q: Does the 13F show all of ARK's exposure including ETFs and derivatives?

A: No. Form 13F discloses long equity positions registered on US exchanges and certain ADRs, but it does not include derivatives, short positions, cash balances, or intra-quarter trades. For comprehensive exposure analysis, combine 13F data with ETF holdings, prospectuses, and real-time flow data.

Q: How should institutions interpret ARK's higher concentration relative to the S&P 500?

A: Higher concentration indicates greater idiosyncratic risk and potential for tracking error versus broad benchmarks. Institutions should evaluate position sizes relative to liquidity, stress-test scenarios for headline shocks, and consider whether the active risk aligns with portfolio objectives and governance constraints.

Bottom Line

ARK's May 12, 2026 13F shows a smaller but more concentrated public-equity footprint, with total reported long positions around $8.9 billion and top holdings comprising the bulk of valuation risk; the filing is a clear signal of high-conviction thematic positioning with attendant liquidity and timing risks. Institutional investors should treat the filing as a directional input, not a complete portfolio picture, and calibrate sizing to liquidity tolerance and governance mandates.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.